

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | exogenous drug catabolic process (GO:0042738) | 9.59069298 |
| 2 | drug catabolic process (GO:0042737) | 8.97230312 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 8.54989794 |
| 4 | cellular glucuronidation (GO:0052695) | 7.66426653 |
| 5 | glucuronate metabolic process (GO:0019585) | 7.34746764 |
| 6 | uronic acid metabolic process (GO:0006063) | 7.34746764 |
| 7 | urea metabolic process (GO:0019627) | 6.95095138 |
| 8 | omega-hydroxylase P450 pathway (GO:0097267) | 6.86921713 |
| 9 | negative regulation of fibrinolysis (GO:0051918) | 6.82440798 |
| 10 | regulation of fibrinolysis (GO:0051917) | 6.65683671 |
| 11 | drug metabolic process (GO:0017144) | 6.65315427 |
| 12 | glyoxylate metabolic process (GO:0046487) | 6.44614471 |
| 13 | nitrogen cycle metabolic process (GO:0071941) | 6.34254024 |
| 14 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.08420950 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.04214760 |
| 16 | L-phenylalanine catabolic process (GO:0006559) | 6.04214760 |
| 17 | urea cycle (GO:0000050) | 5.94955260 |
| 18 | regulation of triglyceride catabolic process (GO:0010896) | 5.81072077 |
| 19 | bile acid and bile salt transport (GO:0015721) | 5.80953128 |
| 20 | bile acid metabolic process (GO:0008206) | 5.77636652 |
| 21 | L-phenylalanine metabolic process (GO:0006558) | 5.66151796 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.66151796 |
| 23 | fibrinolysis (GO:0042730) | 5.63462885 |
| 24 | ethanol oxidation (GO:0006069) | 5.59843211 |
| 25 | regulation of protein activation cascade (GO:2000257) | 5.58831251 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.55538722 |
| 27 | oxidative demethylation (GO:0070989) | 5.52289999 |
| 28 | bile acid biosynthetic process (GO:0006699) | 5.35826750 |
| 29 | phenylpropanoid metabolic process (GO:0009698) | 5.35506471 |
| 30 | hormone catabolic process (GO:0042447) | 5.35111384 |
| 31 | negative regulation of sterol transport (GO:0032372) | 5.30954845 |
| 32 | negative regulation of cholesterol transport (GO:0032375) | 5.30954845 |
| 33 | regulation of complement activation (GO:0030449) | 5.18523462 |
| 34 | alkaloid metabolic process (GO:0009820) | 5.02195313 |
| 35 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.81182614 |
| 36 | protein carboxylation (GO:0018214) | 4.81182614 |
| 37 | phospholipid efflux (GO:0033700) | 4.78702955 |
| 38 | flavonoid metabolic process (GO:0009812) | 4.68416495 |
| 39 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.68125673 |
| 40 | aromatic amino acid family catabolic process (GO:0009074) | 4.54030642 |
| 41 | blood coagulation, intrinsic pathway (GO:0007597) | 4.53769392 |
| 42 | ethanol metabolic process (GO:0006067) | 4.50263740 |
| 43 | negative regulation of blood coagulation (GO:0030195) | 4.49764967 |
| 44 | negative regulation of hemostasis (GO:1900047) | 4.49764967 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 4.49662842 |
| 46 | heme transport (GO:0015886) | 4.40716244 |
| 47 | polyketide metabolic process (GO:0030638) | 4.29079422 |
| 48 | doxorubicin metabolic process (GO:0044598) | 4.29079422 |
| 49 | daunorubicin metabolic process (GO:0044597) | 4.29079422 |
| 50 | arginine metabolic process (GO:0006525) | 4.26733540 |
| 51 | triglyceride homeostasis (GO:0070328) | 4.23386929 |
| 52 | acylglycerol homeostasis (GO:0055090) | 4.23386929 |
| 53 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.23293053 |
| 54 | regulation of bile acid biosynthetic process (GO:0070857) | 4.19490748 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.18062355 |
| 56 | angiotensin maturation (GO:0002003) | 4.13526464 |
| 57 | negative regulation of coagulation (GO:0050819) | 4.12480169 |
| 58 | regulation of cholesterol esterification (GO:0010872) | 4.12401873 |
| 59 | serine family amino acid catabolic process (GO:0009071) | 4.12058263 |
| 60 | intestinal absorption (GO:0050892) | 4.07806208 |
| 61 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.06492434 |
| 62 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.05365950 |
| 63 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.05365950 |
| 64 | high-density lipoprotein particle remodeling (GO:0034375) | 4.04600973 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.01285001 |
| 66 | cholesterol efflux (GO:0033344) | 3.98432788 |
| 67 | glycine metabolic process (GO:0006544) | 3.97198899 |
| 68 | S-adenosylmethionine metabolic process (GO:0046500) | 3.95948562 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.93972837 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.93972837 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.93972837 |
| 72 | primary alcohol catabolic process (GO:0034310) | 3.92714947 |
| 73 | intestinal cholesterol absorption (GO:0030299) | 3.92470956 |
| 74 | regulation of plasminogen activation (GO:0010755) | 3.92358829 |
| 75 | protein activation cascade (GO:0072376) | 3.87184440 |
| 76 | drug transmembrane transport (GO:0006855) | 3.84033343 |
| 77 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.82150742 |
| 78 | complement activation, classical pathway (GO:0006958) | 3.75784306 |
| 79 | acute-phase response (GO:0006953) | 3.70123275 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.69758165 |
| 81 | complement activation (GO:0006956) | 3.65018005 |
| 82 | * xenobiotic metabolic process (GO:0006805) | 3.64872388 |
| 83 | lipoprotein transport (GO:0042953) | 3.64546754 |
| 84 | drug transport (GO:0015893) | 3.60647011 |
| 85 | NADH metabolic process (GO:0006734) | 3.60030593 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.59982139 |
| 87 | vitamin biosynthetic process (GO:0009110) | 3.59624771 |
| 88 | fructose metabolic process (GO:0006000) | 3.59044853 |
| 89 | positive regulation of lipid catabolic process (GO:0050996) | 3.55612558 |
| 90 | reverse cholesterol transport (GO:0043691) | 3.51036147 |
| 91 | alpha-linolenic acid metabolic process (GO:0036109) | 3.39781038 |
| 92 | response to mercury ion (GO:0046689) | 3.39287277 |
| 93 | lipoprotein metabolic process (GO:0042157) | 3.36766477 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 3.33816964 |
| 95 | positive regulation of hemostasis (GO:1900048) | 3.33816964 |
| 96 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.33425223 |
| 97 | regulation of humoral immune response (GO:0002920) | 3.30527984 |
| 98 | tyrosine metabolic process (GO:0006570) | 3.29263605 |
| 99 | protein-lipid complex assembly (GO:0065005) | 3.24340493 |
| 100 | steroid catabolic process (GO:0006706) | 3.24046433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.62523934 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.08936770 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.85221194 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.17424211 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.04953036 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.28218622 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.17529777 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44420232 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.36903765 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.86152301 |
| 11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.80118169 |
| 12 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.73748555 |
| 13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10892021 |
| 14 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.07206090 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.90234754 |
| 16 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.88737565 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.86684344 |
| 18 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.82443569 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.70635920 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.62806760 |
| 21 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.57403591 |
| 22 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.54238885 |
| 23 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.53022891 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.42861154 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42059963 |
| 26 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38877415 |
| 27 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.38047881 |
| 28 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33862042 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.32914617 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.28676472 |
| 31 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25425146 |
| 32 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.25045706 |
| 33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.21201924 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18534882 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.16975371 |
| 36 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.13867469 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.13079146 |
| 38 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.12907126 |
| 39 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.08661640 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05223224 |
| 41 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.02492176 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.00290234 |
| 43 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99551248 |
| 44 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.98910191 |
| 45 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.97409040 |
| 46 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94173596 |
| 47 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93526854 |
| 48 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93165683 |
| 49 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92035875 |
| 50 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.90243619 |
| 51 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90030519 |
| 52 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89825142 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.89656895 |
| 54 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.88983919 |
| 55 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.86275507 |
| 56 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.86020597 |
| 57 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85150876 |
| 58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.85035225 |
| 59 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84638769 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.83060297 |
| 61 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.82949263 |
| 62 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.81369839 |
| 63 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.77642802 |
| 64 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77600421 |
| 65 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.76603723 |
| 66 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74000132 |
| 67 | NFYA_21822215_ChIP-Seq_K562_Human | 0.73602418 |
| 68 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.73193481 |
| 69 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.71116992 |
| 70 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.70756281 |
| 71 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70610979 |
| 72 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.70400118 |
| 73 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.69463552 |
| 74 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.69219650 |
| 75 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.69188225 |
| 76 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.66521235 |
| 77 | SA1_27219007_Chip-Seq_Bcells_Human | 0.65928249 |
| 78 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.65705370 |
| 79 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.65442546 |
| 80 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65299155 |
| 81 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.64886269 |
| 82 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.64473692 |
| 83 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62446338 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.62371534 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62352089 |
| 86 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.61700973 |
| 87 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.60771191 |
| 88 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60233613 |
| 89 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.60184418 |
| 90 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.60093124 |
| 91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.59615186 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.59511300 |
| 93 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.59332365 |
| 94 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.59321955 |
| 95 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.58709802 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.58559559 |
| 97 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.57842264 |
| 98 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57460279 |
| 99 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.56870901 |
| 100 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.56214741 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.29687993 |
| 2 | MP0005360_urolithiasis | 7.48092387 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.55851713 |
| 4 | MP0005365_abnormal_bile_salt | 5.96686353 |
| 5 | MP0001666_abnormal_nutrient_absorption | 4.43342259 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 4.35438664 |
| 7 | MP0003252_abnormal_bile_duct | 3.86525105 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 3.60428123 |
| 9 | MP0003195_calcinosis | 3.49548403 |
| 10 | MP0003868_abnormal_feces_composition | 3.36840153 |
| 11 | MP0009840_abnormal_foam_cell | 3.21370966 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.77913019 |
| 13 | MP0005332_abnormal_amino_acid | 2.39687066 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.32406816 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.22537708 |
| 16 | MP0009697_abnormal_copulation | 2.15870752 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.05283980 |
| 18 | MP0001764_abnormal_homeostasis | 1.73944064 |
| 19 | MP0000609_abnormal_liver_physiology | 1.72655004 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.69833223 |
| 21 | MP0003183_abnormal_peptide_metabolism | 1.63308271 |
| 22 | MP0003191_abnormal_cellular_cholesterol | 1.58668456 |
| 23 | MP0009643_abnormal_urine_homeostasis | 1.41374625 |
| 24 | MP0005319_abnormal_enzyme/_coenzyme | 1.18501463 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.14628064 |
| 26 | MP0005670_abnormal_white_adipose | 1.07819386 |
| 27 | MP0005636_abnormal_mineral_homeostasis | 1.05282912 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.01286432 |
| 29 | MP0004147_increased_porphyrin_level | 1.00001903 |
| 30 | MP0005451_abnormal_body_composition | 0.98295385 |
| 31 | MP0005408_hypopigmentation | 0.98140428 |
| 32 | MP0010155_abnormal_intestine_physiology | 0.98042124 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 0.94034289 |
| 34 | MP0003879_abnormal_hair_cell | 0.91360687 |
| 35 | MP0009379_abnormal_foot_pigmentation | 0.88122926 |
| 36 | MP0003718_maternal_effect | 0.87346987 |
| 37 | MP0009642_abnormal_blood_homeostasis | 0.87091871 |
| 38 | MP0008469_abnormal_protein_level | 0.85305440 |
| 39 | MP0000598_abnormal_liver_morphology | 0.83090548 |
| 40 | MP0005409_darkened_coat_color | 0.79789192 |
| 41 | MP0005535_abnormal_body_temperature | 0.79636643 |
| 42 | MP0002971_abnormal_brown_adipose | 0.79548102 |
| 43 | MP0000604_amyloidosis | 0.75434925 |
| 44 | MP0005376_homeostasis/metabolism_phenot | 0.74100580 |
| 45 | MP0010368_abnormal_lymphatic_system | 0.71983845 |
| 46 | MP0005166_decreased_susceptibility_to | 0.70950019 |
| 47 | MP0005395_other_phenotype | 0.69708736 |
| 48 | MP0002136_abnormal_kidney_physiology | 0.68802275 |
| 49 | MP0009763_increased_sensitivity_to | 0.67528146 |
| 50 | MP0009764_decreased_sensitivity_to | 0.67412788 |
| 51 | MP0003638_abnormal_response/metabolism_ | 0.66199611 |
| 52 | MP0003656_abnormal_erythrocyte_physiolo | 0.59063716 |
| 53 | MP0009053_abnormal_anal_canal | 0.58957213 |
| 54 | MP0001664_abnormal_digestion | 0.57742955 |
| 55 | MP0008872_abnormal_physiological_respon | 0.57581389 |
| 56 | MP0004043_abnormal_pH_regulation | 0.57572013 |
| 57 | MP0005448_abnormal_energy_balance | 0.56885889 |
| 58 | MP0002078_abnormal_glucose_homeostasis | 0.55732117 |
| 59 | MP0002132_abnormal_respiratory_system | 0.53457269 |
| 60 | MP0009785_altered_susceptibility_to | 0.52691661 |
| 61 | MP0005334_abnormal_fat_pad | 0.50356404 |
| 62 | MP0001756_abnormal_urination | 0.50048518 |
| 63 | MP0003186_abnormal_redox_activity | 0.48539030 |
| 64 | MP0000249_abnormal_blood_vessel | 0.48322466 |
| 65 | MP0000566_synostosis | 0.47543007 |
| 66 | MP0001661_extended_life_span | 0.47173643 |
| 67 | MP0003866_abnormal_defecation | 0.47173386 |
| 68 | MP0005266_abnormal_metabolism | 0.45578341 |
| 69 | MP0005023_abnormal_wound_healing | 0.45355922 |
| 70 | MP0000477_abnormal_intestine_morphology | 0.44788849 |
| 71 | MP0001845_abnormal_inflammatory_respons | 0.44502192 |
| 72 | MP0003011_delayed_dark_adaptation | 0.43822165 |
| 73 | MP0005464_abnormal_platelet_physiology | 0.43720742 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 0.43121717 |
| 75 | MP0009115_abnormal_fat_cell | 0.42806161 |
| 76 | MP0001663_abnormal_digestive_system | 0.42397631 |
| 77 | MP0001765_abnormal_ion_homeostasis | 0.42194401 |
| 78 | MP0005058_abnormal_lysosome_morphology | 0.41216513 |
| 79 | MP0000538_abnormal_urinary_bladder | 0.40435363 |
| 80 | MP0002796_impaired_skin_barrier | 0.39921551 |
| 81 | MP0003300_gastrointestinal_ulcer | 0.38371961 |
| 82 | MP0008874_decreased_physiological_sensi | 0.36639158 |
| 83 | MP0006036_abnormal_mitochondrial_physio | 0.36448817 |
| 84 | MP0003953_abnormal_hormone_level | 0.35783254 |
| 85 | MP0000462_abnormal_digestive_system | 0.35561396 |
| 86 | MP0005187_abnormal_penis_morphology | 0.34587417 |
| 87 | MP0005381_digestive/alimentary_phenotyp | 0.34208703 |
| 88 | MP0003329_amyloid_beta_deposits | 0.32505954 |
| 89 | MP0002168_other_aberrant_phenotype | 0.31641771 |
| 90 | MP0000467_abnormal_esophagus_morphology | 0.31400137 |
| 91 | MP0002249_abnormal_larynx_morphology | 0.30247777 |
| 92 | MP0001881_abnormal_mammary_gland | 0.29377120 |
| 93 | MP0000490_abnormal_crypts_of | 0.29198115 |
| 94 | MP0009765_abnormal_xenobiotic_induced | 0.29067194 |
| 95 | MP0002098_abnormal_vibrissa_morphology | 0.28485247 |
| 96 | MP0003690_abnormal_glial_cell | 0.28294283 |
| 97 | MP0010352_gastrointestinal_tract_polyps | 0.27560517 |
| 98 | MP0005666_abnormal_adipose_tissue | 0.26651256 |
| 99 | MP0001915_intracranial_hemorrhage | 0.26269256 |
| 100 | MP0003959_abnormal_lean_body | 0.25130092 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 9.46178603 |
| 2 | Hypobetalipoproteinemia (HP:0003563) | 8.53731393 |
| 3 | Deep venous thrombosis (HP:0002625) | 7.93505735 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.88655937 |
| 5 | Complement deficiency (HP:0004431) | 6.83342647 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.65996026 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.21641387 |
| 8 | Conjugated hyperbilirubinemia (HP:0002908) | 6.03124769 |
| 9 | Abnormality of complement system (HP:0005339) | 5.75210510 |
| 10 | Systemic lupus erythematosus (HP:0002725) | 5.70861419 |
| 11 | Fat malabsorption (HP:0002630) | 5.02222685 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.87671575 |
| 13 | Xanthomatosis (HP:0000991) | 4.78036854 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.69896978 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.53067189 |
| 16 | Joint hemorrhage (HP:0005261) | 4.39659458 |
| 17 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.22819082 |
| 18 | Abnormality of proline metabolism (HP:0010907) | 4.21990516 |
| 19 | Hydroxyprolinuria (HP:0003080) | 4.21990516 |
| 20 | Glomerulonephritis (HP:0000099) | 4.19115114 |
| 21 | Steatorrhea (HP:0002570) | 4.00513327 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91609916 |
| 23 | Hyperglycinuria (HP:0003108) | 3.82730437 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 3.77670568 |
| 25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.64896390 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.64896390 |
| 27 | Hyperammonemia (HP:0001987) | 3.61689826 |
| 28 | Abnormality of vitamin metabolism (HP:0100508) | 3.54363976 |
| 29 | Malnutrition (HP:0004395) | 3.52247955 |
| 30 | Rickets (HP:0002748) | 3.46015385 |
| 31 | Nephritis (HP:0000123) | 3.36624659 |
| 32 | Generalized aminoaciduria (HP:0002909) | 3.34910306 |
| 33 | Abnormality of urine glucose concentration (HP:0011016) | 3.26564146 |
| 34 | Glycosuria (HP:0003076) | 3.26564146 |
| 35 | Spontaneous abortion (HP:0005268) | 3.12077246 |
| 36 | Hyperglycinemia (HP:0002154) | 3.04542384 |
| 37 | Hemorrhage of the eye (HP:0011885) | 2.98736666 |
| 38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.98629179 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.91841155 |
| 40 | Abnormality of the intrinsic pathway (HP:0010989) | 2.88661889 |
| 41 | Osteomalacia (HP:0002749) | 2.88023987 |
| 42 | Hyperphosphaturia (HP:0003109) | 2.87614477 |
| 43 | Acanthocytosis (HP:0001927) | 2.87349478 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.86627364 |
| 45 | Vascular calcification (HP:0004934) | 2.86379633 |
| 46 | Epidermoid cyst (HP:0200040) | 2.75514647 |
| 47 | Delayed CNS myelination (HP:0002188) | 2.70746467 |
| 48 | Hypercholesterolemia (HP:0003124) | 2.65371717 |
| 49 | Abnormal urine phosphate concentration (HP:0012599) | 2.59008853 |
| 50 | Proximal tubulopathy (HP:0000114) | 2.52727164 |
| 51 | Cardiovascular calcification (HP:0011915) | 2.51821183 |
| 52 | Metabolic acidosis (HP:0001942) | 2.50655663 |
| 53 | Hyperbilirubinemia (HP:0002904) | 2.47918824 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.44833883 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.41708807 |
| 56 | Irritability (HP:0000737) | 2.36825234 |
| 57 | Gingival bleeding (HP:0000225) | 2.36683048 |
| 58 | Widely patent fontanelles and sutures (HP:0004492) | 2.34411367 |
| 59 | Alkalosis (HP:0001948) | 2.33360349 |
| 60 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32947385 |
| 61 | Hypophosphatemia (HP:0002148) | 2.27608822 |
| 62 | Poikilocytosis (HP:0004447) | 2.26756812 |
| 63 | Mitral stenosis (HP:0001718) | 2.20674624 |
| 64 | Hypophosphatemic rickets (HP:0004912) | 2.17820502 |
| 65 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.14952000 |
| 66 | Hypoalphalipoproteinemia (HP:0003233) | 2.12880780 |
| 67 | Nephrolithiasis (HP:0000787) | 2.09616047 |
| 68 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.09018696 |
| 69 | Elevated alkaline phosphatase (HP:0003155) | 2.07709562 |
| 70 | Abnormality of methionine metabolism (HP:0010901) | 2.07248170 |
| 71 | Abnormality of vitamin B metabolism (HP:0004340) | 2.06266912 |
| 72 | Nausea (HP:0002018) | 2.04216448 |
| 73 | Pigmentary retinal degeneration (HP:0001146) | 2.04037701 |
| 74 | Reduced antithrombin III activity (HP:0001976) | 2.03100016 |
| 75 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.02951179 |
| 76 | Confusion (HP:0001289) | 2.00014420 |
| 77 | Hepatocellular carcinoma (HP:0001402) | 1.98273533 |
| 78 | Cerebral palsy (HP:0100021) | 1.97209156 |
| 79 | Purpura (HP:0000979) | 1.96667191 |
| 80 | Facial shape deformation (HP:0011334) | 1.94111182 |
| 81 | Potter facies (HP:0002009) | 1.94111182 |
| 82 | Ileus (HP:0002595) | 1.90982185 |
| 83 | Gout (HP:0001997) | 1.89446818 |
| 84 | Abdominal distention (HP:0003270) | 1.88050298 |
| 85 | Hyperuricemia (HP:0002149) | 1.86295627 |
| 86 | Increased purine levels (HP:0004368) | 1.86295627 |
| 87 | Lethargy (HP:0001254) | 1.85125600 |
| 88 | Thrombophlebitis (HP:0004418) | 1.84454218 |
| 89 | Pancreatitis (HP:0001733) | 1.80188061 |
| 90 | Chronic diarrhea (HP:0002028) | 1.79567632 |
| 91 | Bifid scrotum (HP:0000048) | 1.78988991 |
| 92 | Pulmonary embolism (HP:0002204) | 1.76478845 |
| 93 | Joint swelling (HP:0001386) | 1.72564822 |
| 94 | Megaloblastic anemia (HP:0001889) | 1.72290867 |
| 95 | Focal segmental glomerulosclerosis (HP:0000097) | 1.70574716 |
| 96 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.70387161 |
| 97 | Skin nodule (HP:0200036) | 1.69768134 |
| 98 | Dicarboxylic aciduria (HP:0003215) | 1.67572658 |
| 99 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.67572658 |
| 100 | Abnormality of the Achilles tendon (HP:0005109) | 1.66625083 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 6.15540535 |
| 2 | ERN1 | 5.12575493 |
| 3 | RIPK1 | 4.31942508 |
| 4 | MST1R | 4.10443251 |
| 5 | FGFR4 | 2.65044837 |
| 6 | MAP3K12 | 2.58714812 |
| 7 | PRKG2 | 2.45059608 |
| 8 | EPHA2 | 2.36020666 |
| 9 | TYK2 | 2.29404319 |
| 10 | PIK3CG | 2.12951261 |
| 11 | PIK3CA | 2.10580138 |
| 12 | MAP3K2 | 2.07184685 |
| 13 | EPHA3 | 1.83556134 |
| 14 | MAP3K3 | 1.77902274 |
| 15 | PRPF4B | 1.76386156 |
| 16 | PRKACG | 1.54135854 |
| 17 | MYLK | 1.52844979 |
| 18 | MET | 1.46911069 |
| 19 | FGFR3 | 1.45357915 |
| 20 | PDK2 | 1.38331872 |
| 21 | PTK6 | 1.35007828 |
| 22 | IRAK3 | 1.31782660 |
| 23 | TBK1 | 1.30768315 |
| 24 | PRKAA2 | 1.28124684 |
| 25 | ABL2 | 1.27263797 |
| 26 | EPHA4 | 1.27224178 |
| 27 | TESK2 | 1.27038581 |
| 28 | LMTK2 | 1.26541444 |
| 29 | STK39 | 1.25505486 |
| 30 | MAPK11 | 1.21316126 |
| 31 | NLK | 1.18246842 |
| 32 | PDPK1 | 1.18230285 |
| 33 | MAP3K1 | 1.16786038 |
| 34 | EPHB1 | 1.16229423 |
| 35 | OXSR1 | 1.15749757 |
| 36 | MAP3K10 | 1.06207967 |
| 37 | ERBB2 | 1.03220298 |
| 38 | PRKCZ | 0.94858971 |
| 39 | TRIB3 | 0.93243712 |
| 40 | FER | 0.93239767 |
| 41 | AKT3 | 0.89765379 |
| 42 | IGF1R | 0.86241606 |
| 43 | JAK1 | 0.83853120 |
| 44 | KSR2 | 0.82555601 |
| 45 | NEK9 | 0.82184423 |
| 46 | GRK6 | 0.82106077 |
| 47 | PDK1 | 0.80337068 |
| 48 | MAP3K11 | 0.79916027 |
| 49 | JAK2 | 0.75209648 |
| 50 | MAP2K2 | 0.75096406 |
| 51 | STK24 | 0.74579066 |
| 52 | PRKCA | 0.70010608 |
| 53 | SIK1 | 0.69945673 |
| 54 | MAP2K4 | 0.64708528 |
| 55 | RET | 0.60780668 |
| 56 | MAP3K5 | 0.59605616 |
| 57 | EPHB2 | 0.59132419 |
| 58 | ZAP70 | 0.57995510 |
| 59 | MAPKAPK3 | 0.57853434 |
| 60 | DYRK1B | 0.55760310 |
| 61 | CDK6 | 0.53218284 |
| 62 | NEK1 | 0.52985227 |
| 63 | PRKACA | 0.51832652 |
| 64 | TAOK1 | 0.50522539 |
| 65 | TNIK | 0.50274008 |
| 66 | MATK | 0.50211377 |
| 67 | CASK | 0.50092637 |
| 68 | SRC | 0.49927076 |
| 69 | PRKG1 | 0.48804232 |
| 70 | MST4 | 0.48000156 |
| 71 | CAMK2G | 0.46374404 |
| 72 | PINK1 | 0.43033998 |
| 73 | MAP2K6 | 0.40277064 |
| 74 | BMPR2 | 0.39299985 |
| 75 | MAP3K6 | 0.38876005 |
| 76 | NTRK3 | 0.38090898 |
| 77 | GRK1 | 0.38027814 |
| 78 | IRAK1 | 0.37521551 |
| 79 | PIM1 | 0.37130037 |
| 80 | ICK | 0.37026502 |
| 81 | PRKAA1 | 0.35700750 |
| 82 | PTK2 | 0.33623226 |
| 83 | PBK | 0.33011410 |
| 84 | TAOK3 | 0.33007338 |
| 85 | PRKCD | 0.32270606 |
| 86 | BCR | 0.32103629 |
| 87 | TESK1 | 0.31198270 |
| 88 | TAOK2 | 0.30948457 |
| 89 | CAMKK2 | 0.30729991 |
| 90 | CSF1R | 0.29742593 |
| 91 | PDGFRA | 0.29462505 |
| 92 | DDR2 | 0.29154966 |
| 93 | SCYL2 | 0.28574745 |
| 94 | IKBKE | 0.27998415 |
| 95 | MAP3K14 | 0.27608130 |
| 96 | DAPK2 | 0.25950027 |
| 97 | MAP4K1 | 0.25850881 |
| 98 | CDC42BPA | 0.25273351 |
| 99 | PIM2 | 0.24630558 |
| 100 | PRKCG | 0.24267889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.85911446 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.80791432 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47571299 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.36003860 |
| 5 | * Retinol metabolism_Homo sapiens_hsa00830 | 3.23359338 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.05751874 |
| 7 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.98919068 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.97201571 |
| 9 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.96959285 |
| 10 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.90126894 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.75647101 |
| 12 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.70620139 |
| 13 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.69059494 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.41326893 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.17321008 |
| 16 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.17268860 |
| 17 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05959209 |
| 18 | Bile secretion_Homo sapiens_hsa04976 | 2.04004779 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02507427 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.02188455 |
| 21 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.00634246 |
| 22 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.98594860 |
| 23 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.96423778 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93118191 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.88563341 |
| 26 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.73958167 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.62604159 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.59024881 |
| 29 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.46201949 |
| 30 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.33212627 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30640716 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.23542214 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.22909425 |
| 34 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.15496255 |
| 35 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13468016 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.06276688 |
| 37 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.02599492 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.01045923 |
| 39 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95279108 |
| 40 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.94960130 |
| 41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.91074456 |
| 42 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.90313377 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.89178259 |
| 44 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.87914536 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.86476040 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85675610 |
| 47 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85637217 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.85137022 |
| 49 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.84222798 |
| 50 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.83521647 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.81682882 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.81378233 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77226061 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76588393 |
| 55 | Carbon metabolism_Homo sapiens_hsa01200 | 0.73976562 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.73185036 |
| 57 | Mineral absorption_Homo sapiens_hsa04978 | 0.69080780 |
| 58 | ABC transporters_Homo sapiens_hsa02010 | 0.67008781 |
| 59 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.64077083 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.57238165 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56046250 |
| 62 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.50845989 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.50205296 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.48914658 |
| 65 | Sulfur relay system_Homo sapiens_hsa04122 | 0.41670976 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.39456090 |
| 67 | Lysine degradation_Homo sapiens_hsa00310 | 0.31382258 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30961483 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.29892035 |
| 70 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.29633144 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26784996 |
| 72 | Insulin resistance_Homo sapiens_hsa04931 | 0.18568555 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.17333649 |
| 74 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.16051841 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13709163 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.12756888 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.12338251 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.11163235 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11053292 |
| 80 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.10232558 |
| 81 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.08650085 |
| 82 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.04981902 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04914611 |
| 84 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04734880 |
| 85 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | -0.2062340 |
| 86 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1939446 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1841227 |
| 88 | Hepatitis C_Homo sapiens_hsa05160 | -0.1635345 |
| 89 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1320453 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1319845 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1266356 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | -0.1252048 |
| 93 | * Serotonergic synapse_Homo sapiens_hsa04726 | -0.1186674 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1090514 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0769471 |
| 96 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0684452 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.0648106 |
| 98 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0638904 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0404833 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0365300 |

